NeueHealth, Inc. (NYSE:NEUE) Short Interest Down 30.3% in February

NeueHealth, Inc. (NYSE:NEUE) was the target of a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 12,400 shares, a decrease of 30.3% from the January 31st total of 17,800 shares. Based on an average daily volume of 36,500 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.5% of the company’s shares are short sold.

Analysts Set New Price Targets

Separately, Royal Bank of Canada reduced their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research note on Monday, December 9th.

Insider Buying and Selling at NeueHealth

In other news, CEO George Lawrence Mikan III sold 31,798 shares of the business’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $233,079.34. Following the transaction, the chief executive officer now directly owns 146,539 shares of the company’s stock, valued at $1,074,130.87. The trade was a 17.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jay Matushak sold 4,970 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $36,430.10. Following the completion of the transaction, the chief financial officer now directly owns 17,747 shares in the company, valued at approximately $130,085.51. This trade represents a 21.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 58,658 shares of company stock valued at $377,034. 64.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On NeueHealth

Hedge funds and other institutional investors have recently modified their holdings of the business. Partners Group Holding AG bought a new stake in NeueHealth in the third quarter worth about $463,000. Northern Trust Corp grew its holdings in NeueHealth by 66.8% during the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares during the period. Finally, Virtu Financial LLC purchased a new stake in NeueHealth in the fourth quarter worth $76,000. Hedge funds and other institutional investors own 63.88% of the company’s stock.

NeueHealth Stock Down 0.1 %

NEUE traded down $0.01 during trading on Wednesday, hitting $7.32. 14,866 shares of the company’s stock were exchanged, compared to its average volume of 24,474. The stock has a market cap of $60.60 million, a P/E ratio of -0.14 and a beta of 0.58. The business’s 50 day moving average is $7.35 and its two-hundred day moving average is $5.91. NeueHealth has a fifty-two week low of $3.79 and a fifty-two week high of $11.35.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.